| Literature DB >> 29228072 |
Michael Daniel1, Sara Keller1,2,3, Mohammad Mozafarihashjin4,5, Amit Pahwa1,6, Christine Soong7,8,9.
Abstract
Treatment of asymptomatic bacteriuria (ASB) frequently lacks appropriate indication, yet remains prevalent across settings. Numerous guidelines, professional societies, and campaigns such as Choosing Wisely advocate against this low-value practice. Efforts aimed at reducing unnecessary treatment of ASB demonstrate improved costs, and avoidable harm without increased risk of adverse events. We propose an evidence-based implementation guide to aid practitioners in reducing inappropriate treatment of ASB.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29228072 DOI: 10.1001/jamainternmed.2017.7290
Source DB: PubMed Journal: JAMA Intern Med ISSN: 2168-6106 Impact factor: 21.873